• Tom Gani SutedjaEmail author


Electrocautery (EC) and argon plasma coagulation (APC) use electrons to coagulate tissue. Proper tissue heating to acquire sufficient coagulation lessens the risk of profuse hemorrhage before performing mechanical tissue debulking. Equipment setup is easy, making it practical for emergency use. The effect of tissue coagulation is clearly visible for the bronchoscopist.

The availability of various reusable probes for both the rigid and flexible bronchoscopes – either in using the contact or noncontact mode – provides practical alternatives for intraluminal tumor debulking in the daily routine of a bronchoscopy practice.

The use of various bronchoscopic instruments for immediate tumor debulking and curative treatment of early lung cancer or benign lesions is an obvious example of advances in minimally invasive bronchoscopic techniques.


Argon Plasma Coagulation Central Airway Flexible Bronchoscope Tissue Coagulation Rigid Scope 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested Reading

  1. 1.
    Barlow DE. Endoscopic applications of electrosurgery: a review of basic principles. Gastrointest Endoscop. 1982;14:61–3.Google Scholar
  2. 2.
  3. 3.
    Hooper RG, Jackson FN. Endobronchial electrocautery. Chest. 1985;87:712–4.PubMedCrossRefGoogle Scholar
  4. 4.
    Hooper RG. Electrocautery in endobronchial therapy. A letter to the editor. Chest. 2000;117:1820.PubMedCrossRefGoogle Scholar
  5. 5.
    Sutedja G, van Kralingen K, Schramel FM, et al. Fibreoptic bronchoscopic electrosurgery under local anaesthesia for rapid palliation in patients with central airway malignancies: a preliminary report. Thorax. 1994;49:1243–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Grund KE, Storek D, Farin G. Endoscopic argon plasma coagulation (APC) first clinical experiences in flexible endoscopy. Endosc Surg Allied Technol. 1994;2:42–6.PubMedGoogle Scholar
  7. 7.
    Reichle G, Freitag L, Kullmann HJ, et al. Argon plasma coagulation in bronchology: a new method–alternative or complementary? Pneumologie. 2000;54:508–16.PubMedCrossRefGoogle Scholar
  8. 8.
    Sutedja G, Bolliger CT. Endobronchial electrocautery and argon plasma coagulation. Interventional bronchoscopy. Prog Respir Res. 2000;30:120–32. Basel Karger.CrossRefGoogle Scholar
  9. 9.
    van Boxem TJ, Westerga J, Venmans BJ, et al. Tissue effects of bronchoscopic electrocautery: bronchoscopic appearance and histologic changes of bronchial wall after electrocautery. Chest. 2000;117:887–91.PubMedCrossRefGoogle Scholar
  10. 10.
    See bronchoscopic videoclips at
  11. 11.
    van Boxem T, Muller M, Venmans B, et al. Nd-YAG laser versus bronchoscopic electrocautery for palliation of symptomatic airway obstruction: a cost-effectiveness study. Chest. 1999;116:1108–12.PubMedCrossRefGoogle Scholar
  12. 12.
    Coulter TD, Mehta AC. The heat is on: impact of endobronchial electrosurgery on the need for Nd-YAG laser photoresection. Chest. 2000;118:516–21.PubMedCrossRefGoogle Scholar
  13. 13.
    Morice RC, Ece T, Ece F, et al. Endobronchial argon plasma coagulation for treatment of hemoptysis and neoplastic airway obstruction. Chest. 2001;119:781–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Toty L, Personne C, Colchen A, et al. Bronchoscopic management of tracheal lesions using Nd:YAG laser. Thorax. 1981;36:175–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Dumon JF, Reboud E, Garbe L, et al. Treatment of tracheobronchial lesions by laser photoresection. Chest. 1982;81:278–84.PubMedCrossRefGoogle Scholar
  16. 16.
    Dumon JF, Meric B, Bourcereau J, et al. Principles for safety in application of Nd:YAG laser in bronchology. Chest. 1984;86:278–84.CrossRefGoogle Scholar
  17. 17.
    Cavaliere S, Foccoli P, Farina P. Nd:YAG laser bronchoscopy: a 5-year experience with 1,396 applications in 1,000 patients. Chest. 1988;94:15–21.PubMedCrossRefGoogle Scholar
  18. 18.
    Dumon JF. A dedicated tracheobronchial stent. Chest. 1990;97:328–32.PubMedCrossRefGoogle Scholar
  19. 19.
    Bolliger CT, Mathur PN, Beamis JF, et al. European Respiratory Society/American Thoracic Society. ERS/ATS statement on interventional pulmonology. European Respiratory Society/American Thoracic Society. Eur Respir J. 2002;19:356–73.PubMedCrossRefGoogle Scholar
  20. 20.
    Ernst A, Gerard A, Silvestri SA, et al. Interventional pulmonary procedures guidelines from the American College of Chest Physicians. Chest. 2003;123:1693–717.PubMedCrossRefGoogle Scholar
  21. 21.
    Bolliger CT, Sutedja G, Strausz J, et al. Therapeutic bronchoscopy with immediate effect: laser, electrocautery, argon plasma coagulation and stents. Eur Respir J. 2006;27:1258–71.PubMedCrossRefGoogle Scholar
  22. 22.
    van Boxem AJ, Westerga J, Venmans BJ, et al. Photodynamic therapy, Nd-YAG laser and electrocautery for treating early-stage intraluminal cancer: which to choose? Lung Cancer. 2001;31:31–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Furuse K, Fukuoka M, Kato H, et al. A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. J Clin Oncol. 1993;11:1852–7.PubMedGoogle Scholar
  24. 24.
    Cortese DA, Edell ES, Kinsey JH. Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc. 1997;72:595–602.PubMedGoogle Scholar
  25. 25.
    Kawaguchi T, Furuse K, Kawahara M, et al. Histological examination of bronchial mucosa after photodynamic therapy showing no selectivity of effect between tumour and normal mucosa. Lasers Med Sci. 1998;13:265–70.CrossRefGoogle Scholar
  26. 26.
    Grosjean P, Wagnieres G, Fontolliet C, et al. Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II. Br J Cancer. 1998;77:1989–95.PubMedCrossRefGoogle Scholar
  27. 27.
    Dumot JA, Vargo 2nd JJ, Falk GW, et al. An open-label, prospective trial of cryospray ablation for Barrett’s esophagus high-grade ­dysplasia and early esophageal cancer in high-risk patients. Gastrointest Endosc. 2009;70:635–44.PubMedCrossRefGoogle Scholar
  28. 28.
    Ernst A, Simoff M, Ost D, et al. Prospective risk-adjusted morbidity and mortality outcome analysis after therapeutic bronchoscopic procedures: results of a multi-institutional outcomes database. Chest. 2008;134:514–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60:615–22.PubMedCrossRefGoogle Scholar
  30. 30.
    Lederle EF. Lobectomy versus limited resection in T1N0 lung cancer. Ann Thorac Surg. 1996;62:1249–50.PubMedCrossRefGoogle Scholar
  31. 31.
    Pasic A, Postmus PE, Sutedja G. What is early lung cancer? A review of the literature. Lung Cancer. 2004;45:267–77.PubMedCrossRefGoogle Scholar
  32. 32.
    Lam S, MacAulay C, Hung J, et al. Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. J Thorac Cardiovasc Surg. 1993;105:1035–40.PubMedGoogle Scholar
  33. 33.
    Moro-Sibilot D, Aubert A, Diab S, et al. Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer. Eur Respir J. 2005;26:480–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Janssen-Heijnen ML, Maas HA, Houterman S, et al. Comorbidity in older surgical cancer patients: influence on patient care and outcome. Eur J Cancer. 2007;43:2179–93.PubMedCrossRefGoogle Scholar
  35. 35.
    Sutedja G, van Boxem AJ, Postmus PE. The curative potential of intraluminal bronchoscopic treatment for early-stage non-small-cell lung cancer. Clin Lung Cancer. 2001;2:264–70.PubMedCrossRefGoogle Scholar
  36. 36.
    Woolner LB, Fontana RS, Cortese DA, et al. Roentgenographically occult lung cancer: pathologic findings and frequency of multicentricity during a 10-year period. Mayo Clin Proc. 1984;59:453–66.PubMedCrossRefGoogle Scholar
  37. 37.
    Herder GJ, Breuer RH, Comans EF, et al. Positron emission tomography scans can detect radiographically occult lung cancer in the central airways. J Clin Oncol. 2001;19:4271–2.PubMedGoogle Scholar
  38. 38.
    Sutedja G, Codrington H, Risse EK, et al. Autofluorescence bronchoscopy improves staging of radiographically occult lung cancer and has an impact on therapeutic strategy. Chest. 2001;120:1327–32.PubMedCrossRefGoogle Scholar
  39. 39.
    Miyazu Y, Miyazawa T, Kurimoto N, et al. Endobronchial ultrasonography in the assessment of centrally located early-stage lung cancer before photodynamic therapy. Am J Respir Crit Care Med. 2002;165:832–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Pasic A, Brokx HA, Vonk Noordegraaf A, et al. Cost-effectiveness of early intervention: comparison between intraluminal bronchoscopic treatment and surgical resection for T1N0 lung cancer patients. Respiration. 2004;71:391–6.PubMedCrossRefGoogle Scholar
  41. 41.
    Endo C, Sagawa M, Sato M, et al. What kind of hilar lung cancer can be a candidate for segmentectomy with curative intent? Retrospective clinicopathological study of completely resected roentgenographically occult bronchogenic squamous cell carcinoma. Lung Cancer. 1998;21:93–9.PubMedCrossRefGoogle Scholar
  42. 42.
    Fujimura S, Sakurada A, Sagawa M, et al. A therapeutic approach to roentgenographically occult squamous cell carcinoma of the lung. Cancer. 2000;89:2445–8.PubMedCrossRefGoogle Scholar
  43. 43.
    McWilliams A, MacAulay C, Gazdar AF, et al. Innovative molecular and imaging approaches for the detection of lung cancer and its ­precursor lesions. Oncogene. 2002;21:6949–59.PubMedCrossRefGoogle Scholar
  44. 44.
    Thiberville L, Payne P, Vielkinds J, et al. Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus. Cancer Res. 1995;55:5133–9.PubMedGoogle Scholar
  45. 45.
    Gustafson AM, Soldi R, Anderlind C, et al. Airway PI3K pathway activation is an early and reversible event in lung cancer development. Sci Transl Med. 2010;2(26):26ra25. Scholar
  46. 46.
    Bach PB. Is our natural history model of lung-cancer wrong? Review. Lancet Oncol. 2008;9:693–7.PubMedCrossRefGoogle Scholar
  47. 47.
    Lee P, Sutedja G. Lung cancer screening: has there been any progress? Computed tomography and autofluorescence bronchoscopy. Review. Curr Opin Pulm Med. 2007;13:243–8.PubMedCrossRefGoogle Scholar
  48. 48.
    MacMahon H, Austin JH, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology. 2005;237:395–400.PubMedCrossRefGoogle Scholar
  49. 49.
    Campbell L, Blackhall F, Thatcher N. Gefitinib for the treatment of non-small-cell lung cancer. Expert Opin Pharmacother. 2010;11:1343–57.PubMedCrossRefGoogle Scholar
  50. 50.
    Asano F. Virtual bronchoscopic navigation. Clin Chest Med. 2010;31:75–85.PubMedCrossRefGoogle Scholar
  51. 51.
    Okunaka T, Hiyoshi T, Furukawa K, et al. Lung cancers treated with photodynamic therapy and surgery. Diagn Ther Endosc. 1999;5:155–60.PubMedCrossRefGoogle Scholar
  52. 52.
    Schuurman B, Postmus PE, van Mourik JC, et al. Combined use of autofluorescence bronchoscopy and argon plasma coagulation enables less extensive resection of radiographically occult lung cancer. Respiration. 2004;71:410–1.PubMedCrossRefGoogle Scholar
  53. 53.
    Mathur PN, Edell E, Sutedja G, et al. Treatment of early stage nonsmall cell lung cancer. American College of Chest Physicians. Chest. 2003;123(Suppl):176S–80.PubMedCrossRefGoogle Scholar
  54. 54.
    Ernst A, Eberhardt R, Wahidi M, et al. Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest. 2006;129:734–7.PubMedCrossRefGoogle Scholar
  55. 55.
    Shah H, Garbe L, Nussbaum E, Dumon JF, et al. Benign tumors of the tracheobronchial tree. Endoscopic characteristics and role of laser resection. Chest. 1995;107:1744–51.PubMedCrossRefGoogle Scholar
  56. 56.
    Brokx HA, Risse EK, Paul MA, et al. Initial bronchoscopic treatment for patients with intraluminal bronchial carcinoids. J Thorac Cardiovasc Surg. 2007;133:973–8.PubMedCrossRefGoogle Scholar
  57. 57.
    Kunst PW, Sutedja G, Golding RP, et al. Unusual pulmonary lesions: a juvenile bronchopulmonary fibrosarcoma. J Clin Oncol. 2002;20:2745–51.PubMedGoogle Scholar
  58. 58.
    Skov BG, Krasnik M, Lantuejoul S, et al. Reclassification of neuroendocrine tumors improves the separation of carcinoids and the prediction of survival. J Thorac Oncol. 2008;3:1410–5.PubMedCrossRefGoogle Scholar
  59. 59.
    Potti A, Mukherjee S, Petersen R, et al. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med. 2006;355:570–80.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Pulmonary Medicine & Thoracic OncologyVrije University Academic Medical CenterAmsterdamThe Netherlands

Personalised recommendations